Thymelaea hirsuta
Thymelaea hirsuta · Accepted scientific name
Scientific literature: Very Sparse (5 studies) · ★☆☆☆☆
Thymelaea hirsuta is a botanical species recognized for its diverse pharmacological potential and rich chemical profile. The plant's leaves and flowers contain significant bioactive compounds, including chlorogenic acid, coumarins, esculetin, and feruloylquinic acid. Various preparations, such as ethanolic, ethyl acetate, and water extracts, are utilized to harness these therapeutic properties. Research indicates that these extracts exhibit potent antidiabetic, cytotoxic, anti-HIV, and antiarthritic activities. Consequently, this plant holds great promise in addressing medical conditions such as diabetic nephropathy, cancer, HIV-1, and adjuvant arthritis.
- Synonyms
- Chlamydanthus Hirsutus · Thymelaea Hirsuta Var. Angustifolia · 18 more
- Common names
- Not available
- Family
- Thymelaeaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Flower
Classification
Common Names
Thymelaea hirsuta is a distinctive plant known by a diverse array of regional and linguistic names. In English-speaking regions, it is frequently referred to as Hairy Spurge Flax, a name that reflects its physical characteristics. German speakers identify the species as Haarige Spatzenzunge or Behaarte Spatzenzunge. Various other common names also exist, including Bufalaga hirsuta and Bufalaga marina. Finally, it is recognized by the name Boja marina, highlighting the many ways this single species is categorized across different cultures.
Sources: Catalogue of Life (COL)
Synonyms
Thymelaea hirsuta is a botanical species recognized by several different scientific names throughout taxonomic history. It is frequently identified by the synonyms Chlamydanthus hirsutus and Giardia hirsuta in various botanical records. Researchers also encounter this plant under the nomenclature of Lachnaea hirsuta. Furthermore, the species is linked to the name Passerina hirsuta. This complex lineage even includes the specific designation Passerina hirsuta proles polygalifolia.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Thymelaea hirsuta is a distinct botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further belongs to the order Malvales, showcasing its specific evolutionary placement. Moving down the taxonomic hierarchy, the plant is a member of the family Thymelaeaceae. Finally, it is categorized under the specific genus Thymelaea, completing its unique biological profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Thymelaeaceae |
| Genus | Thymelaea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Thymelaea hirsuta is a plant species widely distributed across the northern regions of the African continent. Its presence is notably established throughout the diverse landscapes of North Africa. Specifically, the species can be found flourishing in the territories of Algeria and Egypt. It also maintains a significant range within the borders of Libya and Morocco. Furthermore, the plant is commonly documented growing throughout the coastal and inland areas of Tunisia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Thymelaea hirsuta is characterized by its distinct shrub-like growth form. As a self-supporting plant, it maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Thymelaea hirsuta is a medicinal plant that demonstrates a diverse range of therapeutic properties across various biological studies. Research indicates that its extracts possess significant antidiabetic activity, helping to normalize blood glucose levels and protect against pancreatic and liver damage. Additionally, the plant has shown potent antiarthritic effects by effectively inhibiting inflammation in animal models. Studies involving phytochemical isolation have also highlighted its cytotoxic potential, particularly against specific cancer cell lines. Furthermore, the discovery of new triflavanone compounds from this species underscores its promising antiproliferative capabilities in combating tumor progression.
Compounds
Thymelaea hirsuta is a medicinal plant endemic to Algeria that has long been utilized in traditional folk medicine to treat various ailments. Recent phytochemical profiling using LC-MS/MS has identified several biologically active molecules within its different organs, particularly the flowers. The plant is rich in hydroxycinamic acids, such as chlorogenic acid and feruloylquinic acid. Additionally, the species contains significant amounts of coumarins like esculetin and rutarensin. The presence of these compounds, along with flavonoids like isochamaejasmine, highlights the plant's immense potential for industrial pharmaceutical exploitation.
Conditions
Thymelaea hirsuta exhibits significant therapeutic potential against various medical conditions through its diverse bioactive compounds. The plant's isolated triflavanone compound demonstrates potent cytotoxic activity against HCT-116 colorectal cancer cells. Regarding viral infections, extracts from the plant show strong activity against HIV-1 wt and are effective against HIV-1 variants carrying clinically relevant NNRTI and NRTI mutations. Furthermore, the plant has proven capable of treating HIV-1 by preventing syncytia formation during the replication cycle. Finally, its aqueous extracts contribute to the management of diabetes by successfully reducing HbAc1 levels in diabetic models.
Preparations
Thymelaea hirsuta is prepared as ethanolic extracts to evaluate its phytochemical compositions, antimicrobial activities, and potential as a PPARα/γ dual agonist. The plant is also prepared as ethyl acetate extracts, which have demonstrated potent and selective activity against HIV-1 and effectiveness in protecting against pancreatic islet degeneration. Additionally, Thymelaea hirsuta is prepared as a water extract (WE) to test its antihyperglycemic properties in diabetic models. Researchers further utilize the plant as an aqueous extract (AqTh) to investigate its ability to prevent renal fibrosis and liver damage. Overall, these various preparations of Thymelaea hirsuta, including general extracts, serve as essential tools for discovering its diverse medicinal properties.
Parts used
Thymelaea hirsuta is a medicinal plant endemic to Algeria that holds significant potential for pharmaceutical development. Scientific investigations into its various anatomical components reveal that the plant possesses distinct morphological parts, including the leaf and the flower. Research utilizing liquid chromatography shows that the flowers, in particular, serve as a privileged source of bioactive polyphenols such as flavonoids and coumarins. Similarly, extracts derived from the leaves have demonstrated potent and selective inhibitory activity against HIV-1 in laboratory settings. By studying these specific plant organs, researchers can better understand the chemical diversity that supports the traditional medicinal uses of this species.